NYSE:NGVT - Ingevity Stock Price, News, & Analysis

$91.02
+0.81 (+0.90 %)
(As of 06/17/2019 04:00 PM ET)
Today's Range
$89.48
Now: $91.02
$92.0350
50-Day Range
$86.34
MA: $95.60
$115.15
52-Week Range
$74.98
Now: $91.02
$120.41
Volume189,674 shs
Average Volume323,954 shs
Market Capitalization$3.81 billion
P/E Ratio22.04
Dividend YieldN/A
Beta1.91
Ingevity Corporation manufactures and sells specialty chemicals and carbon materials in the United States and internationally. The company operates through two segments, Performance Materials and Performance Chemicals. The Performance Materials segment engineers, manufactures, and sells hardwood-based and chemically activated carbon products primarily for use in gasoline vapor emission control systems in cars, trucks, motorcycles, and boats. Read More…

Industry, Sector and Symbol

Industry Chemicals & allied products
Sub-IndustryN/A
SectorBasic Materials
Previous SymbolNASDAQ:NGVT
CUSIPN/A
Phone843-740-2300

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$1.13 billion
Cash Flow$5.6047 per share
Book Value$8.07 per share

Profitability

Net Income$169.10 million

Miscellaneous

Employees1,750
Market Cap$3.81 billion
Next Earnings Date7/24/2019 (Estimated)
OptionableOptionable

Receive NGVT News and Ratings via Email

Sign-up to receive the latest news and ratings for NGVT and its competitors with MarketBeat's FREE daily newsletter.

Ingevity (NYSE:NGVT) Frequently Asked Questions

What is Ingevity's stock symbol?

Ingevity trades on the New York Stock Exchange (NYSE) under the ticker symbol "NGVT."

How were Ingevity's earnings last quarter?

Ingevity Corp (NYSE:NGVT) issued its earnings results on Wednesday, May, 1st. The company reported $0.99 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.97 by $0.02. The business had revenue of $276.80 million for the quarter, compared to analysts' expectations of $288.07 million. Ingevity had a net margin of 13.70% and a return on equity of 53.81%. The business's revenue for the quarter was up 17.7% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $0.79 EPS. View Ingevity's Earnings History.

When is Ingevity's next earnings date?

Ingevity is scheduled to release their next quarterly earnings announcement on Wednesday, July 24th 2019. View Earnings Estimates for Ingevity.

What price target have analysts set for NGVT?

8 brokerages have issued twelve-month price targets for Ingevity's shares. Their predictions range from $68.00 to $130.00. On average, they expect Ingevity's stock price to reach $99.75 in the next year. This suggests a possible upside of 9.6% from the stock's current price. View Analyst Price Targets for Ingevity.

What is the consensus analysts' recommendation for Ingevity?

8 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Ingevity in the last year. There are currently 2 hold ratings and 6 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Ingevity.

Has Ingevity been receiving favorable news coverage?

Media coverage about NGVT stock has been trending somewhat positive recently, InfoTrie Sentiment reports. The research group identifies negative and positive press coverage by analyzing more than six thousand news and blog sources. The firm ranks coverage of publicly-traded companies on a scale of -5 to 5, with scores closest to five being the most favorable. Ingevity earned a news sentiment score of 1.4 on InfoTrie's scale. They also gave news headlines about the company a news buzz of 10.0 out of 10, indicating that recent press coverage is extremely likely to have an impact on the stock's share price in the next few days. View News Stories for Ingevity.

Are investors shorting Ingevity?

Ingevity saw a drop in short interest during the month of May. As of May 15th, there was short interest totalling 487,700 shares, a drop of 8.8% from the April 15th total of 534,900 shares. Based on an average trading volume of 398,600 shares, the short-interest ratio is currently 1.2 days. Approximately 1.2% of the company's shares are sold short. View Ingevity's Current Options Chain.

Who are some of Ingevity's key competitors?

What other stocks do shareholders of Ingevity own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Ingevity investors own include NVIDIA (NVDA), Paypal (PYPL), Citigroup (C), CVS Health (CVS), General Electric (GE), Quaker Chemical (KWR), Verizon Communications (VZ), Costco Wholesale (COST), Alphabet (GOOG) and IDEXX Laboratories (IDXX).

Who are Ingevity's key executives?

Ingevity's management team includes the folowing people:
  • Mr. D. Michael Wilson, Pres, CEO & Director (Age 56)
  • Mr. John C. Fortson, Exec. VP, CFO & Treasurer (Age 52)
  • Ms. Katherine Pryor Burgeson, Exec. VP, Gen. Counsel & Sec. (Age 61)
  • Mr. Stuart Edward Woodcock Jr., Exec. VP & Pres of Performance Materials (Age 53)
  • Mr. Michael P. Smith, Exec. VP and Pres of Performance Chemicals, Strategy & Bus. Devel. (Age 58)

Who are Ingevity's major shareholders?

Ingevity's stock is owned by many different of retail and institutional investors. Top institutional shareholders include BlackRock Inc. (11.35%), Wells Fargo & Company MN (2.50%), FMR LLC (1.73%), Neuberger Berman Group LLC (1.67%), Chilton Investment Co. LLC (1.62%) and OppenheimerFunds Inc. (1.61%). Company insiders that own Ingevity stock include John C Fortson, Katherine Pryor Burgeson and Phillip John Platt. View Institutional Ownership Trends for Ingevity.

Which major investors are selling Ingevity stock?

NGVT stock was sold by a variety of institutional investors in the last quarter, including BlackRock Inc., Pictet Asset Management Ltd., OppenheimerFunds Inc., Kornitzer Capital Management Inc. KS, Marshall Wace LLP, FMR LLC, Wells Fargo & Company MN and Copper Rock Capital Partners LLC. Company insiders that have sold Ingevity company stock in the last year include John C Fortson, Katherine Pryor Burgeson and Phillip John Platt. View Insider Buying and Selling for Ingevity.

Which major investors are buying Ingevity stock?

NGVT stock was bought by a variety of institutional investors in the last quarter, including Victory Capital Management Inc., Columbus Circle Investors, American International Group Inc., Rice Hall James & Associates LLC, Redwood Investments LLC, JPMorgan Chase & Co., Federated Investors Inc. PA and Retirement Systems of Alabama. View Insider Buying and Selling for Ingevity.

How do I buy shares of Ingevity?

Shares of NGVT can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Ingevity's stock price today?

One share of NGVT stock can currently be purchased for approximately $91.02.

How big of a company is Ingevity?

Ingevity has a market capitalization of $3.81 billion and generates $1.13 billion in revenue each year. The company earns $169.10 million in net income (profit) each year or $4.13 on an earnings per share basis. Ingevity employs 1,750 workers across the globe.View Additional Information About Ingevity.

What is Ingevity's official website?

The official website for Ingevity is http://www.ingevity.com/.

How can I contact Ingevity?

Ingevity's mailing address is 5255 Virginia Avenue, North Charleston SC, 29406. The company can be reached via phone at 843-740-2300 or via email at [email protected]


MarketBeat Community Rating for Ingevity (NYSE NGVT)

Community Ranking:  2.6 out of 5 (star star)
Outperform Votes:  271 (Vote Outperform)
Underperform Votes:  255 (Vote Underperform)
Total Votes:  526
MarketBeat's community ratings are surveys of what our community members think about Ingevity and other stocks. Vote "Outperform" if you believe NGVT will outperform the S&P 500 over the long term. Vote "Underperform" if you believe NGVT will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 6/17/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel